Reward-learning and the novelty-seeking personality: A between-and within-subjects study of the effects of dopamine agonists on young parkinsons patients

Brain

Volumn 132, Issue 9, 2009, Pages 2385-2395

  Bódi, Nikoletta ^a   Kéri, Szabolcs ^a   Nagy, Helga ^b   Moustafa, Ahmed ^c   Myers, Catherine E ^d   Daw, Nathaniel ^e   Dibó, György ^f   Takáts, Annamária ^b   Bereczki, Dániel ^b   Gluck, Mark A ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c RUTGERS UNIVERSITY   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e NEW YORK UNIVERSITY   (United States)

^f UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Dopamine; Novelty seeking; Parkinsons disease; Pramipexole; Reward; Ropinirole

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PRAMIPEXOLE; ROPINIROLE;

ARTICLE; AVOIDANCE BEHAVIOR; CLASSIFICATION; CLINICAL ASSESSMENT; COGNITION; CORPUS STRIATUM; CORRELATION ANALYSIS; DRUG EFFECT; FOLLOW UP; HUMAN; IMPULSE CONTROL DISORDER; LEARNING; LONGITUDINAL STUDY; NEGATIVE FEEDBACK; PARKINSON DISEASE; PERSONALITY DISORDER; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROBABILITY; PUNISHMENT; REWARD; TEMPERAMENT; TEST RETEST RELIABILITY; TREATMENT DURATION;

EID: 70349922298     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp094     Document Type: Article

References (58)

1. Balleine BW, Delgado MR, Hikosaka O. The role of the dorsal striatum in reward and decision-making. J Neurosci 2007; 27: 8161-8165.
2. Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, et al. Modeling sensitization to stimulants in humans: an [11C]raclopride/ positron emission tomography study in healthy men. Arch Gen Psychiatry 2006; 63: 1386-1395.
3. Bolikal P, Myers CE, Patel R, Ropp L, Daw N, Gluck MA. Punishment-based learning correlates with a putative index of serotonin in healthy young adults. Cognitive Neuroscience Society Annual Meeting Program, 2007, F148 [abstract].
4. Cirino PT, Chin CE, Sevcik RA, Wolf M, Lovett M, Morris RD. Measuring socioeconomic status: reliability and preliminary validity for different approaches. Assessment 2002; 9: 145-155.
5. Cloninger RC. The temperament and character inventory (TCI): a guide to its development and use. St. Louis, MO: Center for Psychobiology of Personality, Washington University; 1994.
6. Cohen MX, Schoene-Bake JC, Elger CE, Weber B. Connectivity-based segregation of the human striatum predicts personality characteristics. Nat Neurosci 2009; 12: 32-34.
7. Cools R, Altamirano L, D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 2006; 44: 1663-1673.
8. Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands. Cereb Cortex 2001; 11: 1136-1143.
9. Cools R, Barker RA, Sahakian BJ, Robbins TW. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003; 41: 1431-1441.
10. Cools R, Roberts AC, Robbins TW. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 2008; 12: 31-40.
11. Daw ND, Kakade S, Dayan P. Opponent interactions between serotonin and dopamine. Neural Netw 2002; 15: 603-616.
12. Daw ND, O'Doherty JP, Dayan P, Seymour B, Dolan RJ. Cortical substrates for exploratory decisions in humans. Nature 2006; 441: 876-879.
13. Delgado MR, Li J, Schiller D, Phelps EA. The role of the striatum in aversive learning and aversive prediction errors. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3787-3800.
14. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson's disease. Arch Neurol 2005; 62: 1377-1381.
15. Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ. Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology 2005; 65: 1570-1574.
16. Ferrara JM, Stacy M. Impulse-control disorders in Parkinson's disease. CNS Spectr 2008; 13: 690-698.
17. Frank MJ. Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. J Cogn Neurosci 2005; 17: 51-72.
18. Frank MJ, O'Reilly RC. A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci 2006; 120: 497-517.
19. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in Parkinsonism. Science 2007; 318: 1309-1312.
20. Frank MJ, Seeberger LC, O'Reilly RC. By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science 2004; 306: 1940-1943.
21. Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T, Riederer P. Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum. J Neural Transm 2003; 110: 1119-1127.
22. Gibb WR, Lees AJ. A comparison of clinical and pathological features of young-and old-onset Parkinson's disease. Neurology 1988; 38: 1402-1406.
23. Goerendt IK, Lawrence AD, Brooks DJ. Reward processing in health and Parkinson's disease: neural organization and reorganization. Cereb Cortex 2004; 14: 73-80.
24. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
25. Ishihara L, Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 2006; 21: 1066-1072.
26. Jacobs H, Heberlein I, Vieregge A, Vieregge P. Personality traits in young patients with Parkinson's disease. Acta Neurol Scand 2001; 103: 82-87.
27. Kaasinen V, Aalto S, Na° gren K, Rinne JO. Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease. Mov Disord 2004; 19: 1348-1351.
28. Kaasinen V, Nurmi E, Bergman J, Eskola O, Solin O, Sonninen P, et al. Personality traits and brain dopaminergic function in Parkinson's disease. Proc Natl Acad Sci USA 2001; 98: 13272-13277.
29. Keitz M, Koerts J, Kortekaas R, Renken R, de Jong BM, Leenders KL. Prefrontal cortex and striatal activation by feedback in Parkinson's disease. Brain Res 2008; 1236: 225-233.
30. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988; 318: 876-880
31. Kü nig G, Leenders KL, Martin-Sö lch C, Missimer J, Magyar S, Schultz W. Reduced reward processing in the brains of Parkinsonian patients. Neuroreport 2000; 11: 3681-3687.
32. Lang AE, Fahn S. Assessment of Parkinson's disease. In: Munsat TL, editor. Quantification of neurologic deficit. Boston, MA: Butterworth-Heinemann; 1989. p. 285-309.
33. Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A. Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002; 27: 1027-1035.
34. Ljungberg T, Apicella P, Schultz W. Responses of monkey dopamine neurons during learning of behavioral reactions. J Neurophysiol 1992; 67: 145-163.
35. Menza M. The personality associated with Parkinson's disease. Curr Psychiatry Rep 2000; 2: 421-426.
36. Montague PR, King-Casas B, Cohen JD. Imaging valuation models in human choice. Annu Rev Neurosci 2006; 29: 417-448.
37. Mountjoy CQ, Roth M. Studies in the relationship between depressive disorders and anxiety states. Part 1. Rating scales. J Affect Disord 1982; 4: 127-147. (Pubitemid 12076974)
38. Moustafa AA, Cohen MX, Sherman SJ, Frank MJ. A role for dopamine in temporal decision making and reward maximization in parkinsonism. J Neurosci 2008; 28: 12294-12304.
39. Ondo WG, Lai D. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord 2008; 14: 28-32.
40. Packard MG, Knowlton BJ. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 2002; 25: 563-593.
41. Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1430-1435.
42. Perretta JG, Pari G, Beninger RJ. Effects of Parkinson disease on two putative non-declarative learning tasks: probabilistic classification and gambling. Cogn Behav Neurol 2005; 18: 185-192.
43. Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature 2006; 442: 1042-1045.
44. Rowe JB, Hughes L, Ghosh BC, Eckstein D, Williams-Gray CH, Fallon S, et al. Parkinson's disease and dopaminergic therapy-differential effects on movement, reward and cognition. Brain 2008; 131: 2094-2105
45. Ró zsa S, Kállai J, Osváth A, Bá nki MC. Temperamentum és Karakter: Cloninger pszichobioló giai modellje. A Cloninger-féle Temperamentum és Karakter Kérdo00 ív felhaszná ló i kézikö nyve. Medicina: Budapest 2005.
46. Schmidt L, d'Arc BF, Lafargue G, Galanaud D, Czernecki V, Grabli D, et al. Disconnecting force from money: effects of basal ganglia damage on incentive motivation. Brain 2008; 131: 1303-1310.
47. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset Parkinsonism. Lancet Neurol 2006; 5: 355-363.
48. Schultz W. Behavioural theories and the neurophysiology of reward. Annu Rev Psychol 2006; 57: 87-115.
49. Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997; 275: 1593-1599.
50. Seymour B, O'Doherty JP, Dayan P, Koltzenburg M, Jones AK, Dolan RJ, et al. Temporal difference models describe higher-order learning in humans. Nature 2004; 429: 664-667.
51. Shohamy D, Myers CE, Geghman KD, Sage J, Gluck MA. L-dopa impairs learning, but spares generalization, in Parkinson's disease. Neuropsychologia 2006; 44: 774-784.
52. Shohamy D, Myers CE, Kalanithi J, Gluck MA. Basal ganglia and dopamine contributions to probabilistic category learning. Neurosci Biobehav Rev 2008; 32: 219-236.
53. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC. Molecular cloning and characterization of a novel dopamine eceptor (D3) as a target for neuroleptics. Nature 1990; 347: 146-151.
54. Suhara T, Yasuno F, Sudo Y, Yamamoto M, Inoue M, Okubo Y, et al. Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. Neuroimage 2001; 13: 891-895.
55. Tomer R, Aharon-Peretz J. Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency. J Neurol Neurosurg Psychiatry 2004; 75: 972-975.
56. Wechsler D. Wechsler Adult Intelligence Scale-Revised Manual. New York, NY: Psychological Corporation; 1981.
57. Wittmann BC, Daw ND, Seymour B, Dolan RJ. Striatal activity underlies novelty-based choice in humans. Neuron 2008; 58: 967-973.
58. Wolters ECh, van der Werf YD, van den Heuvel OA. Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol 2008; 255 (Suppl 5): 48-56